DFX Intelligence
Borrowers
286 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Industry as filed contains “Healthcare” (remove)
Start from
286 borrower groups
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| RxSense Holdings LLC Healthcare services | unattributed | 4 | at least $21.0M | 99c | 0 pts | Mar 12, 2027 | Dec 31, 2022 |
| BioDerm, Inc Life sciences | unattributed | 2 | at least $20.6M | 99c | 1 pts | Jan 31, 2028 | Mar 31, 2023 |
| GoForward, Inc Healthcare services · Life sciences | unattributed | 3 | at least $20.4M | 50c | n/a | unstated | Dec 31, 2022 |
| R•• H•••••••• I•• Life sciences | unattributed | 10 | at least $20.0M | 102c | 0 pts | Dec 23, 2030 | Dec 31, 2021 |
| V•••• M•••••• H•••••••• I•• Healthcare services · Life sciences | Sponsor not establishedpossible: J•• P••••••• L•• (a company of this name is on the sponsor's portfolio page) | 11 | at least $19.2M | 95c | 0 pts | Oct 29, 2031 | Mar 31, 2022 |
| T•• G••• H••••• G••••• L•• Healthcare services | unattributed | 1 | at least $19.1M | 100c | n/a | Jun 1, 2030 | Jun 30, 2026 |
| M••••• L•••• I•• Healthcare services | unattributed | 1 | at least $19.0M | 99c | n/a | Feb 1, 2029 | Mar 31, 2023 |
| E•• H••••• Life sciences | unattributed | 2 | at least $18.9M | 100c | 0 pts | Aug 7, 2030 | Sep 30, 2024 |
| C••••••••• M••••••••• H•••••••• L•• Healthcare services | unattributed | 4 | at least $18.9M | 101c | n/a | Jan 31, 2029 | Mar 31, 2024 |
| H••••• B•••• G•••••• G••• Life sciences | unattributed | 2 | at least $16.9M | 98c | 0 pts | Apr 29, 2033 | Jun 30, 2026 |
| S••••••••• I•• Education | Sponsor not establishedpossible: 1••• C•••••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $16.3M | 100c | n/a | Nov 19, 2031 | Dec 31, 2025 |
| N••• M••••••••• S••••••• C••••••••• Healthcare services | unattributed | 5 | at least $16.0M | 72c | 2 pts | Feb 23, 2029 | Dec 31, 2021 |
| D••• S••••• Healthcare services · Life sciences | Q••••• M••••••••• I••• inferred | 5 | at least $15.8M | 100c | 0 pts | Mar 24, 2033 | Dec 31, 2025 |
| B••••• B••••••••• H••••••• L•• Life sciences | unattributed | 4 | at least $15.1M | 100c | 1 pts | Jun 21, 2029 | Dec 31, 2024 |
| C•••••••• I••••••••• H•••••• L•• Healthcare services | Sponsor not establishedpossible: S••••••• S••••• C•••••• P••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $15.0M | 100c | n/a | Jun 1, 2030 | Jun 30, 2026 |
| H••••••••• G• M•••••• T••••••••• I•• Healthcare services | unattributed | 1 | at least $15.0M | 100c | n/a | Oct 1, 2029 | Dec 31, 2024 |
| V•• M••• L•• Healthcare services | unattributed | 1 | at least $14.6M | 102c | n/a | Dec 18, 2030 | Dec 31, 2025 |
| V••••• B•••• L•••••• Life sciences | unattributed | 2 | at least $14.5M | 99c | 0 pts | Aug 20, 2030 | Sep 30, 2025 |
| B•••• S•••• Life sciences | unattributed | 3 | at least $14.4M | 103c | 6 pts | Jun 30, 2031 | Sep 30, 2024 |
| C•••• L••••••• L•• Healthcare services | unattributed | 2 | at least $14.4M | 100c | 0 pts | May 28, 2031 | Dec 31, 2024 |
| S••••• O•••• Life sciences | Sponsor not establishedpossible: I••••••• C•••••• P•••••••• L•• (a company of this name is on the sponsor's portfolio page) | 2 | at least $14.3M | 101c | 0 pts | Jul 31, 2028 | Dec 31, 2024 |
| E•••• B••••• L•• Life sciences | unattributed | 2 | at least $14.1M | 99c | 0 pts | Mar 12, 2033 | Mar 31, 2026 |
| S••••• S•••• • J•••• C•••••• Healthcare services · Life sciences | M••••• E••••• P•••••••• L•• inferred | 1 | at least $14.0M | 102c | n/a | Mar 25, 2031 | Dec 31, 2024 |
| A•••• M•••••• P•••••••• L•• Life sciences | unattributed | 4 | at least $14.0M | 100c | 1 pts | Jun 10, 2028 | Sep 30, 2021 |
| C••••••••• H•••••••• I•• Life sciences | unattributed | 4 | at least $14.0M | 100c | n/a | Oct 31, 2028 | Dec 31, 2023 |
| J•• P•••••• I•• Healthcare services | unattributed | 2 | at least $13.5M | 99c | n/a | Feb 13, 2032 | Mar 31, 2025 |
| H••••• C••••••• I•• Healthcare services | unattributed | 1 | at least $13.4M | 104c | n/a | Jul 16, 2029 | Sep 30, 2024 |
| N•••• B•••• Life sciences | unattributed | 2 | at least $13.3M | 99c | 0 pts | Jun 24, 2032 | Jun 30, 2025 |
| W••• C••••••••• B••••• L•• Life sciences | unattributed | 2 | at least $13.0M | 100c | 0 pts | Dec 20, 2032 | Dec 31, 2025 |
| L•••••••• H•••••• I•• Healthcare services | unattributed | 8 | at least $12.9M | 98c | 1 pts | Nov 30, 2028 | Dec 31, 2021 |
| S••••••••• D••••• H••••••• I•• L•• Healthcare services | unattributed | 2 | at least $12.6M | 101c | n/a | Nov 1, 2028 | Jun 30, 2024 |
| O••••• H••••• G••••• I•• Healthcare services | unattributed | 1 | at least $12.5M | 99c | n/a | Oct 1, 2029 | Dec 31, 2024 |
| B••••• S••••••••• L••••• Life sciences | unattributed | 2 | at least $11.9M | 101c | n/a | Mar 25, 2028 | Jun 30, 2024 |
| B••••• H•••••• I•• Healthcare services | unattributed | 1 | at least $11.3M | 98c | n/a | Nov 1, 2029 | Dec 31, 2025 |
| P•••••••• C•••••••• Life sciences | unattributed | 3 | at least $10.9M | 95c | n/a | Apr 16, 2032 | Sep 30, 2025 |
| T••••••• H••••• H•••••••• L•• Healthcare services | unattributed | 1 | at least $10.2M | 100c | n/a | Dec 1, 2029 | Dec 31, 2025 |
| R•••••••• A••••••••• F••••• D•••••••• Healthcare services · Life sciences | Sponsor not establishedpossible: B•••••• I••••••••• A••••••• (a company of this name is on the sponsor's portfolio page) | 1 | at least $10.2M | 101c | n/a | Oct 31, 2030 | Dec 31, 2024 |
| G•••• E••••••••• D••••• C••••• P• Life sciences | unattributed | 1 | at least $10.0M | 85c | n/a | Sep 30, 2026 | Dec 31, 2021 |
| A••••• I••••••••• L•• Life sciences | unattributed | 2 | at least $9.9M | 102c | 0 pts | Jun 5, 2031 | Jun 30, 2025 |
| P••••••••• M•••••• C••• L•• Life sciences | unattributed | 2 | at least $9.5M | 100c | n/a | Jul 1, 2032 | Sep 30, 2025 |
| U••• R•••• C•••• I•• Healthcare services · Life sciences | Sponsor not establishedpossible: S••••• P•••••••• L••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $9.2M | 103c | n/a | Jun 20, 2028 | Dec 31, 2022 |
| A••••••• C••• A••••••• H••••• L•• Life sciences | unattributed | 2 | at least $9.1M | 101c | n/a | Aug 20, 2030 | Sep 30, 2025 |
| N•••••• Healthcare services · Life sciences · grade B | unattributed | 1 | at least $9.0M | 99c | n/a | Nov 9, 2029 | Dec 31, 2023 |
| C••••••• Healthcare services · Life sciences | unattributed | 1 | at least $9.0M | 101c | n/a | Aug 1, 2030 | Mar 31, 2026 |
| R•• N•••••• Life sciences | unattributed | 2 | at least $9.0M | 100c | n/a | Oct 17, 2031 | Dec 31, 2024 |
| A•• I••••••• Life sciences | R••••••••• C•••••• P••••••• inferred | 2 | at least $8.6M | 101c | n/a | Mar 19, 2032 | Mar 31, 2025 |
| C••••••••• H••••• H•••••••• L•• Healthcare services | unattributed | 1 | at least $8.5M | 100c | n/a | May 1, 2030 | Dec 31, 2025 |
| A•• Healthcare services · Life sciences | unattributed | 2 | at least $8.5M | 101c | n/a | Sep 30, 2031 | Dec 31, 2024 |
| T••• S••••••• G••••• L•• Healthcare services · Life sciences | A••••• I•••••••• inferred | 15 | at least $8.4M | 99c | n/a | Jan 28, 2033 | Mar 31, 2022 |
| O•••••• Life sciences | unattributed | 5 | at least $7.6M | 101c | n/a | Nov 21, 2030 | Dec 31, 2021 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.